A validation study of the focalpoint gs imaging system for gynecologic cytology screening

Cancer Cytopathology

Volumn 121, Issue 4, 2013, Pages 189-196

  Colgan, Terence J ^a   Bon, Nereo ^b   Clipsham, Susan ^c   Gardiner, Geoffrey ^c   Sumner, Jeff ^c   Walley, Virginia ^b   McLachlin, C Meg ^d  

^a MOUNT SINAI HOSPITAL   (Canada)

^b LifeLabs   (Canada)

^c DYNACARE LABORATORIES   (Canada)

^d LONDON HEALTH SCIENCES CENTRE   (Canada)

Author keywords

Automated cytology; Cervical screening; FocalPoint; Gynecologic cytology; Papanicolaou test

Indexed keywords

ARTICLE; ATYPICAL SQUAMOUS CELL OF UNDETERMINED SIGNIFICANCE; AUTOANALYZER; CANCER CYTODIAGNOSIS; CANCER DIAGNOSIS; CANCER SCREENING; COMPUTER PROGRAM; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST ACCURACY STUDY; DIAGNOSTIC VALUE; DIFFERENTIAL DIAGNOSIS; FALSE NEGATIVE RESULT; FEMALE; HIGH GRADE SQUAMOUS INTRAEPITHELIAL LESION; HUMAN; HUMAN TISSUE; IMAGING SYSTEM; INTERMETHOD COMPARISON; LABORATORY DEVICE; LOW GRADE SQUAMOUS INTRAEPITHELIAL LESION; MAJOR CLINICAL STUDY; PAPANICOLAOU TEST; PRIORITY JOURNAL; SENSITIVITY AND SPECIFICITY; SLIDE PROFILER; TUMOR CLASSIFICATION; UTERINE CERVIX CARCINOMA; UTERINE CERVIX CARCINOMA IN SITU; UTERINE CERVIX CYTOLOGY; VALIDATION STUDY; CANADA; CARCINOMA; CYTODIAGNOSIS; CYTOLOGY; DISEASE CLASSIFICATION; DISEASE SEVERITY; FOCALPOINT GUIDED SCREENING IMAGING SYSTEM; GYNECOLOGY; SCREENING TEST; SQUAMOUS CELL; CANCER GRADING; CLASSIFICATION; COMPARATIVE STUDY; COMPUTER ASSISTED DIAGNOSIS; EARLY DIAGNOSIS; IMAGE PROCESSING; MIDDLE AGED; SQUAMOUS CELL CARCINOMA; UTERINE CERVIX DYSPLASIA; UTERINE CERVIX TUMOR; VAGINA SMEAR;

CERVICAL INTRAEPITHELIAL NEOPLASIA; CYTODIAGNOSIS; DIAGNOSIS, COMPUTER-ASSISTED; EARLY DETECTION OF CANCER; FEMALE; HUMANS; IMAGE PROCESSING, COMPUTER-ASSISTED; MIDDLE AGED; NEOPLASM GRADING; NEOPLASMS, SQUAMOUS CELL; ONTARIO; UTERINE CERVICAL DYSPLASIA; UTERINE CERVICAL NEOPLASMS; VAGINAL SMEARS;

MLCS; MLOWN;

EID: 84878459241     PISSN: None     EISSN: 19346638     Source Type: Journal    
DOI: 10.1002/cncy.21271     Document Type: Article

References (15)

1. Colgan TJ, McLachlin CM, Cotterchio M, Howlett R, Seidenfeld AM, Mai VM. Results of the implementation of liquid-based cytology SurePath in the Ontario screening program. Cancer (Cancer Cytopathol). 2004;102:362-367.
2. BD Diagnostics. The BD FocalPoint Slide Profiler. Franklin Lakes, NJ: BD Diagnostics; 2012. Available at: Http://www.bd.com/tripath/labs/fp-screening. asp. Accessed August 8, 2012.
3. Cancer Care Ontario. The Ontario Cervical Screening Program 2003-2008. Toronto, Ontario: Cancer Care Ontario; 2012. Available at: Https://www. cancercare.on.ca/pcs/screening/cervscreening/hcpresources/. Accessed August 7, 2012.
4. Wilbur DC, Black-Schaffer WS, Luff RD, et al. The Becton Dickinson FocalPoint GS Imaging System: Clinical trials demonstrate significantly improved sensitivity for the detection of important cervical lesions. Am J Clin Pathol. 2009;132:767-775.
5. Kitchener HC, Blanks R, Dunn G, et al. Automation-assisted versus manual reading of cervical cytology (MAVARIC): A randomized controlled trial. Lancet Oncol. 2011;12:56-64.
6. Quality Management Program-Laboratory Services (QMP-LS). Accreditation Requirements and Guidance. Toronto, Ontario: QMPLS, Ontario Medical Association; 2012. Available at: Http://www.qmpls.org/LaboratoryAccreditation/ OLARequirements.aspx. Accessed August 8, 2012.
7. Clinical and Laboratory Standards Institute (formerly the National Committee for Clinical Laboratory Standards [NCCLS]). A Framework for NCCLS Evaluation Protocols; A Report. NCCLS documentEP19-R. Wayne, PA: Clinical and Laboratory Standards Institute; 2009.
8. Sprinthall RC. Basic Statistical Analysis. 7th ed. Boston, MA: Pearson Education Group; 2003.
9. Hunt JL. New applications for old assays and the importance of validation. Cancer (Cancer Cytopathol). 2012;120:3-6.
10. BD Diagnostics. BD FocalPoint GS Imaging System [product insert]. Franklin Lakes, NJ: BD Diagnostics; 2012. Available at: Http://www.bd.com/ tripath/labs/fp-gs-system.asp. Accessed August 8, 2012.
11. British Association for Cytopathology. Recommended Code of Practice for Laboratories Participating in the UK Cervical Screening Programmes. London, United Kingdom: British Association for Cytopathology; 2012. Available at: Http://www.britishcytology.org. uk/resources/resources.asp. Accessed August 27, 2012.
12. College of Medical Laboratory Technologists of Ontario (CMTLO). Practice Guidelines for Medical Laboratory Technologists Practicing in Cytology. Toronto, Ontario: CMTLO; 2008. Available at: Http://www.cmlto.com/index.php?searchword= cytotechnologists&ordering=&searchphrase=all&Itemid=9999&option= com-search. Accessed August 8, 2012.
13. Kitchener HC, Blanks R, Cubie H, et al. MAVARIC a comparison of automation-assisted and manual cervical screening: A randomised controlled trial. Health Technol Assess. 2011;15:iii-iv, ix-xi, 1-170.
14. Levi AW, Chhieng DC, Schofield K, Kowalski D, Harigopal M. Implementation of FocalPoint GS location-guided imaging system. Cancer (Cancer Cytopathol). 2012;120:126-133.
15. Denton KJ, Nuttall D, Cropper A, Desai M; on behalf of the British Association for Cytopathology. Implementation of "No further review" (NFR) using the BC FocalPoint Slide. Profiler. National Health Service Cervical Screening Programme Good Practice Guide No. 4. Sheffield, United Kingdom: National Health Service Cancer Screening Programmes; 2012.Available at: Http://www.britishcytology.org.uk/uploads/NHSCSP%20GPG4%20No% 20further%20review.pdf. Accessed August 27, 2012.